| Dr Obinna Odozor, OD | |
|
909 Taylor Ave, Towson, MD 21286-8311 | |
| (410) 821-6380 | |
| Not Available |
| Full Name | Dr Obinna Odozor |
|---|---|
| Gender | Male |
| Speciality | Optometrist |
| Location | 909 Taylor Ave, Towson, Maryland |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518647049 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | TA2932 (Maryland) | Primary |
| Provider Name | Silver Spring Optometry, Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1336204387 PECOS PAC ID: 1951351626 Enrollment ID: O20050131000340 |
News Archive
The results of studies involving researchers from the MedUni Vienna and Vienna General Hospital Comprehensive Cancer Center show that the effect of immunotherapy on malignant melanoma (black skin cancer) can be improved by combining it with other cancer treatments.
Women who develop blood clots while taking tamoxifen for early-stage breast cancer are more likely to carry a faulty version of a gene involved in clotting than those who do not develop blood clots, a US study has found.
The second of two studies on latrepirdine, recently published in Molecular Psychiatry, demonstrates new potential for the compound in the treatment of Alzheimer's disease, Parkinson's disease, sleep disorders, and other neurodegenerative conditions. An international team led by Mount Sinai School of Medicine scientists found that latrepiridine, known commercially as Dimebon, reduced the level of at least two neurodegeneration-related proteins in mice.
High-risk women with acute coronary syndrome benefit as much as men from a trip to the cardiac cath lab shortly after being hospitalized, according to a study reported recently at the Society for Cardiovascular Angiography and Interventions (SCAI) 29th Annual Scientific Sessions in Chicago.
Ingenix today announced that it has expanded the electronic prescribing (e-prescribing) capabilities of its CareTracker™ EMR solution. The new e-prescribing features are Surescripts® certified and allow physicians to access their patients' prescription histories and drug benefit information as part of an electronic health record.
› Verified 1 days ago
| Provider Name | Rockville Pike Optometry, Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1710043278 PECOS PAC ID: 4688776313 Enrollment ID: O20070226000722 |
News Archive
The results of studies involving researchers from the MedUni Vienna and Vienna General Hospital Comprehensive Cancer Center show that the effect of immunotherapy on malignant melanoma (black skin cancer) can be improved by combining it with other cancer treatments.
Women who develop blood clots while taking tamoxifen for early-stage breast cancer are more likely to carry a faulty version of a gene involved in clotting than those who do not develop blood clots, a US study has found.
The second of two studies on latrepirdine, recently published in Molecular Psychiatry, demonstrates new potential for the compound in the treatment of Alzheimer's disease, Parkinson's disease, sleep disorders, and other neurodegenerative conditions. An international team led by Mount Sinai School of Medicine scientists found that latrepiridine, known commercially as Dimebon, reduced the level of at least two neurodegeneration-related proteins in mice.
High-risk women with acute coronary syndrome benefit as much as men from a trip to the cardiac cath lab shortly after being hospitalized, according to a study reported recently at the Society for Cardiovascular Angiography and Interventions (SCAI) 29th Annual Scientific Sessions in Chicago.
Ingenix today announced that it has expanded the electronic prescribing (e-prescribing) capabilities of its CareTracker™ EMR solution. The new e-prescribing features are Surescripts® certified and allow physicians to access their patients' prescription histories and drug benefit information as part of an electronic health record.
› Verified 1 days ago
| Provider Name | Rockville Optometry, Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1548325798 PECOS PAC ID: 8729180112 Enrollment ID: O20070305000335 |
News Archive
The results of studies involving researchers from the MedUni Vienna and Vienna General Hospital Comprehensive Cancer Center show that the effect of immunotherapy on malignant melanoma (black skin cancer) can be improved by combining it with other cancer treatments.
Women who develop blood clots while taking tamoxifen for early-stage breast cancer are more likely to carry a faulty version of a gene involved in clotting than those who do not develop blood clots, a US study has found.
The second of two studies on latrepirdine, recently published in Molecular Psychiatry, demonstrates new potential for the compound in the treatment of Alzheimer's disease, Parkinson's disease, sleep disorders, and other neurodegenerative conditions. An international team led by Mount Sinai School of Medicine scientists found that latrepiridine, known commercially as Dimebon, reduced the level of at least two neurodegeneration-related proteins in mice.
High-risk women with acute coronary syndrome benefit as much as men from a trip to the cardiac cath lab shortly after being hospitalized, according to a study reported recently at the Society for Cardiovascular Angiography and Interventions (SCAI) 29th Annual Scientific Sessions in Chicago.
Ingenix today announced that it has expanded the electronic prescribing (e-prescribing) capabilities of its CareTracker™ EMR solution. The new e-prescribing features are Surescripts® certified and allow physicians to access their patients' prescription histories and drug benefit information as part of an electronic health record.
› Verified 1 days ago
| Provider Name | Miller Eyecare Olney, Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1366507303 PECOS PAC ID: 5799871638 Enrollment ID: O20071023000604 |
News Archive
The results of studies involving researchers from the MedUni Vienna and Vienna General Hospital Comprehensive Cancer Center show that the effect of immunotherapy on malignant melanoma (black skin cancer) can be improved by combining it with other cancer treatments.
Women who develop blood clots while taking tamoxifen for early-stage breast cancer are more likely to carry a faulty version of a gene involved in clotting than those who do not develop blood clots, a US study has found.
The second of two studies on latrepirdine, recently published in Molecular Psychiatry, demonstrates new potential for the compound in the treatment of Alzheimer's disease, Parkinson's disease, sleep disorders, and other neurodegenerative conditions. An international team led by Mount Sinai School of Medicine scientists found that latrepiridine, known commercially as Dimebon, reduced the level of at least two neurodegeneration-related proteins in mice.
High-risk women with acute coronary syndrome benefit as much as men from a trip to the cardiac cath lab shortly after being hospitalized, according to a study reported recently at the Society for Cardiovascular Angiography and Interventions (SCAI) 29th Annual Scientific Sessions in Chicago.
Ingenix today announced that it has expanded the electronic prescribing (e-prescribing) capabilities of its CareTracker™ EMR solution. The new e-prescribing features are Surescripts® certified and allow physicians to access their patients' prescription histories and drug benefit information as part of an electronic health record.
› Verified 1 days ago
| Provider Name | Bethesda Optometry, Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1568687028 PECOS PAC ID: 3577647460 Enrollment ID: O20080303000203 |
News Archive
The results of studies involving researchers from the MedUni Vienna and Vienna General Hospital Comprehensive Cancer Center show that the effect of immunotherapy on malignant melanoma (black skin cancer) can be improved by combining it with other cancer treatments.
Women who develop blood clots while taking tamoxifen for early-stage breast cancer are more likely to carry a faulty version of a gene involved in clotting than those who do not develop blood clots, a US study has found.
The second of two studies on latrepirdine, recently published in Molecular Psychiatry, demonstrates new potential for the compound in the treatment of Alzheimer's disease, Parkinson's disease, sleep disorders, and other neurodegenerative conditions. An international team led by Mount Sinai School of Medicine scientists found that latrepiridine, known commercially as Dimebon, reduced the level of at least two neurodegeneration-related proteins in mice.
High-risk women with acute coronary syndrome benefit as much as men from a trip to the cardiac cath lab shortly after being hospitalized, according to a study reported recently at the Society for Cardiovascular Angiography and Interventions (SCAI) 29th Annual Scientific Sessions in Chicago.
Ingenix today announced that it has expanded the electronic prescribing (e-prescribing) capabilities of its CareTracker™ EMR solution. The new e-prescribing features are Surescripts® certified and allow physicians to access their patients' prescription histories and drug benefit information as part of an electronic health record.
› Verified 1 days ago
| Provider Name | Aspen Hill Optometry, Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1629293170 PECOS PAC ID: 4486716420 Enrollment ID: O20081229000373 |
News Archive
The results of studies involving researchers from the MedUni Vienna and Vienna General Hospital Comprehensive Cancer Center show that the effect of immunotherapy on malignant melanoma (black skin cancer) can be improved by combining it with other cancer treatments.
Women who develop blood clots while taking tamoxifen for early-stage breast cancer are more likely to carry a faulty version of a gene involved in clotting than those who do not develop blood clots, a US study has found.
The second of two studies on latrepirdine, recently published in Molecular Psychiatry, demonstrates new potential for the compound in the treatment of Alzheimer's disease, Parkinson's disease, sleep disorders, and other neurodegenerative conditions. An international team led by Mount Sinai School of Medicine scientists found that latrepiridine, known commercially as Dimebon, reduced the level of at least two neurodegeneration-related proteins in mice.
High-risk women with acute coronary syndrome benefit as much as men from a trip to the cardiac cath lab shortly after being hospitalized, according to a study reported recently at the Society for Cardiovascular Angiography and Interventions (SCAI) 29th Annual Scientific Sessions in Chicago.
Ingenix today announced that it has expanded the electronic prescribing (e-prescribing) capabilities of its CareTracker™ EMR solution. The new e-prescribing features are Surescripts® certified and allow physicians to access their patients' prescription histories and drug benefit information as part of an electronic health record.
› Verified 1 days ago
| Provider Name | Miller Eye Care Center, Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1588729719 PECOS PAC ID: 6103989496 Enrollment ID: O20090113000462 |
News Archive
The results of studies involving researchers from the MedUni Vienna and Vienna General Hospital Comprehensive Cancer Center show that the effect of immunotherapy on malignant melanoma (black skin cancer) can be improved by combining it with other cancer treatments.
Women who develop blood clots while taking tamoxifen for early-stage breast cancer are more likely to carry a faulty version of a gene involved in clotting than those who do not develop blood clots, a US study has found.
The second of two studies on latrepirdine, recently published in Molecular Psychiatry, demonstrates new potential for the compound in the treatment of Alzheimer's disease, Parkinson's disease, sleep disorders, and other neurodegenerative conditions. An international team led by Mount Sinai School of Medicine scientists found that latrepiridine, known commercially as Dimebon, reduced the level of at least two neurodegeneration-related proteins in mice.
High-risk women with acute coronary syndrome benefit as much as men from a trip to the cardiac cath lab shortly after being hospitalized, according to a study reported recently at the Society for Cardiovascular Angiography and Interventions (SCAI) 29th Annual Scientific Sessions in Chicago.
Ingenix today announced that it has expanded the electronic prescribing (e-prescribing) capabilities of its CareTracker™ EMR solution. The new e-prescribing features are Surescripts® certified and allow physicians to access their patients' prescription histories and drug benefit information as part of an electronic health record.
› Verified 1 days ago
| Provider Name | Kentlands Optometry Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1275774234 PECOS PAC ID: 6305094434 Enrollment ID: O20120914000662 |
News Archive
The results of studies involving researchers from the MedUni Vienna and Vienna General Hospital Comprehensive Cancer Center show that the effect of immunotherapy on malignant melanoma (black skin cancer) can be improved by combining it with other cancer treatments.
Women who develop blood clots while taking tamoxifen for early-stage breast cancer are more likely to carry a faulty version of a gene involved in clotting than those who do not develop blood clots, a US study has found.
The second of two studies on latrepirdine, recently published in Molecular Psychiatry, demonstrates new potential for the compound in the treatment of Alzheimer's disease, Parkinson's disease, sleep disorders, and other neurodegenerative conditions. An international team led by Mount Sinai School of Medicine scientists found that latrepiridine, known commercially as Dimebon, reduced the level of at least two neurodegeneration-related proteins in mice.
High-risk women with acute coronary syndrome benefit as much as men from a trip to the cardiac cath lab shortly after being hospitalized, according to a study reported recently at the Society for Cardiovascular Angiography and Interventions (SCAI) 29th Annual Scientific Sessions in Chicago.
Ingenix today announced that it has expanded the electronic prescribing (e-prescribing) capabilities of its CareTracker™ EMR solution. The new e-prescribing features are Surescripts® certified and allow physicians to access their patients' prescription histories and drug benefit information as part of an electronic health record.
› Verified 1 days ago
| Provider Name | Myeyedr Optometry Of Maryland Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1497124796 PECOS PAC ID: 6002037629 Enrollment ID: O20151102002293 |
News Archive
The results of studies involving researchers from the MedUni Vienna and Vienna General Hospital Comprehensive Cancer Center show that the effect of immunotherapy on malignant melanoma (black skin cancer) can be improved by combining it with other cancer treatments.
Women who develop blood clots while taking tamoxifen for early-stage breast cancer are more likely to carry a faulty version of a gene involved in clotting than those who do not develop blood clots, a US study has found.
The second of two studies on latrepirdine, recently published in Molecular Psychiatry, demonstrates new potential for the compound in the treatment of Alzheimer's disease, Parkinson's disease, sleep disorders, and other neurodegenerative conditions. An international team led by Mount Sinai School of Medicine scientists found that latrepiridine, known commercially as Dimebon, reduced the level of at least two neurodegeneration-related proteins in mice.
High-risk women with acute coronary syndrome benefit as much as men from a trip to the cardiac cath lab shortly after being hospitalized, according to a study reported recently at the Society for Cardiovascular Angiography and Interventions (SCAI) 29th Annual Scientific Sessions in Chicago.
Ingenix today announced that it has expanded the electronic prescribing (e-prescribing) capabilities of its CareTracker™ EMR solution. The new e-prescribing features are Surescripts® certified and allow physicians to access their patients' prescription histories and drug benefit information as part of an electronic health record.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Obinna Odozor, OD 909 Taylor Ave, Towson, MD 21286-8311 Ph: (410) 821-6380 | Dr Obinna Odozor, OD 909 Taylor Ave, Towson, MD 21286-8311 Ph: (410) 821-6380 |
News Archive
The results of studies involving researchers from the MedUni Vienna and Vienna General Hospital Comprehensive Cancer Center show that the effect of immunotherapy on malignant melanoma (black skin cancer) can be improved by combining it with other cancer treatments.
Women who develop blood clots while taking tamoxifen for early-stage breast cancer are more likely to carry a faulty version of a gene involved in clotting than those who do not develop blood clots, a US study has found.
The second of two studies on latrepirdine, recently published in Molecular Psychiatry, demonstrates new potential for the compound in the treatment of Alzheimer's disease, Parkinson's disease, sleep disorders, and other neurodegenerative conditions. An international team led by Mount Sinai School of Medicine scientists found that latrepiridine, known commercially as Dimebon, reduced the level of at least two neurodegeneration-related proteins in mice.
High-risk women with acute coronary syndrome benefit as much as men from a trip to the cardiac cath lab shortly after being hospitalized, according to a study reported recently at the Society for Cardiovascular Angiography and Interventions (SCAI) 29th Annual Scientific Sessions in Chicago.
Ingenix today announced that it has expanded the electronic prescribing (e-prescribing) capabilities of its CareTracker™ EMR solution. The new e-prescribing features are Surescripts® certified and allow physicians to access their patients' prescription histories and drug benefit information as part of an electronic health record.
› Verified 1 days ago
Dr. Samantha Renee Andreaggi, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 920 Providence Rd Ste 100, Towson, MD 21286 Phone: 443-394-8679 | |
Myeyedr. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 825 Dulaney Valley Rd, Space 2135, Towson, MD 21204 Phone: 410-296-0289 | |
Valerie Witaker, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 825 Dulaney Valley Rd, Suite 1335, Towson, MD 21204 Phone: 301-590-9191 Fax: 301-590-3971 | |
Lizanette Paulino, OD Optometrist Medicare: Medicare Enrolled Practice Location: 825 Dulaney Valley Rd Ste 1335, Towson, MD 21204 Phone: 410-823-3830 | |
Martin J Mcginn, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 8625 Pleasant Plains Rd, Towson, MD 21286 Phone: 410-828-5558 Fax: 410-823-6315 | |
Dr. Robert Scott Stutman, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 8601 Lasalle Rd, Suite 108, Towson, MD 21286 Phone: 410-821-6400 Fax: 410-296-4722 | |
Ruxton Towers Eye Associates Optometrist Medicare: Medicare Enrolled Practice Location: 8415 Bellona Lane, Suite 104, Towson, MD 21204 Phone: 410-828-9270 Fax: 410-321-0124 |